Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024
BEIJING,Nov. 25,2024-- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China\'s leading used car retailer,today announced its unaudited financial results for the quarter ende
Tuya Smart Presented at the China Pavilion of COP29, Advocating for a Zero Carbon Future
NEW YORK,Nov. 25,2024-- On November 16,2024,the side event titled "Dialogue with the World: Building a Sustainable Ecosystem for a Zero Carbon Future" took center stage at the China Pavilion
Industry-Leading Features Tailored to Meet the Increasing Demand for Eco-Friendly,Versatile Solutions for Recreation and Work
Lovevery Launches The Real Life Play Kitchen, Bringing Fun and Practical Skills to Children's Play
BOISE,Idaho,Nov. 26,2024-- Lovevery,the global early childhood development brand,today announced the release of The Real Life Play Kitchen. A first-of-its-kind,The Real Life Play Kitchen is unlike t
FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. Announce Strategic Partnership
MOMENCE,Ill.,Nov. 25,2024--FutureCeuticals,Inc. and Global Calcium Pvt.,Ltd. announced today a strategic global sales and manufacturing partnership to expand FutureCeuticals\' portfolio of clinically
CMC Global Drives U.S. Business Success with IT Staffing and Emerging Technology Services
To remain competitive in the digital era,U.S. companies face mounting pressure to secure the right talent and technological solutions. CMC Global,a leading technology provider based in Vietnam,is step
Revenue grows from $6.7 million to $13.9 million FUZHOU,China,Nov. 25,2024-- Shengfeng Development Limited ("Shengfeng" or the "Company") (NASDAQ: SFWL),acontract logistics company
Powering the Future: Innovative Energy Solutions from Korea NEW YORKandSEOUL,South Korea,Nov. 25,2024-- The Korea Innovation Foundation (INNOPOLIS),currently operating the 2024 Global Technology Comme
Food Allergy: LongBio's LP-003 achieves its fourth IND approval
SHANGHAI,Nov. 25,2024--LongBio is proud to announce that the National Medical Products Administration (NMPA,China) has approved the Investigational New Drug (IND) application for LP-003,the company\'s
YONGIN,South Korea,Nov. 26,2024-- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with \'GC1130A\',an innovative new drug